Government Price Cuts Pose Biggest Challenge In China's Drug Sector
This article was originally published in PharmAsia News
Executive Summary
In 2011, China's pharmaceutical industry faces a huge challenge resulting from government price cuts on drugs, Fosun Pharma Vice Chairman and President Yao Fang said